Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Pushes New Board In Fight Against Icahn
Pharmalot
Monday, July 18, 2011 - 10:07am
tags:
Carl Icahn, Forest Labs
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Monday, July 18, 2011 - 10:03am
tags:
Human Genome Sciences, Vertex Pharmaceuticals, Acorda Therapeutics, Dendreon, Avanir, lupus, Benlysta, Incivek, hepatitis C, MS, AMPYRA, Provenge, prostate cancer, Nuedexta, PBA
Talon Therapeutics Submits New Drug Application for Marqibo
Yahoo
Monday, July 18, 2011 - 10:00am
tags:
Talon Therapeuticsl, Marqibo, leukemia
Forest Laboratories depression drug levomilnacipran performs well in late-stage study
Yahoo/AP
Monday, July 18, 2011 - 9:52am
tags:
Forest Labs, depression, levomilnacipran
Novartis May Beat Off Pharmaceutical Blues
WSJ Online
Monday, July 18, 2011 - 9:51am
tags:
Novartis
New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
Yahoo
Monday, July 18, 2011 - 9:50am
tags:
Livalo, HIV protease inhibitor, Eli Lilly
What's in Store for Bristol Myers Squibb at Dapagliflozin FDA Hearing
Seeking Alpha
Monday, July 18, 2011 - 9:49am
tags:
FDA, Dapagliflozin, Bristol-Myers Squibb, diabetes, advisory panels
NuPathe - On A New Route?
RTT News
Sunday, July 17, 2011 - 12:12pm
tags:
Zelrix, migraines, sumatriptan, NuPathe
Teva Drops Most in a Month as Amgen Patent Litigation Resolved
Bloomberg
Sunday, July 17, 2011 - 12:10pm
tags:
Teva Pharmaceuticals, Amgen, Neugranin, Neutroval, legal
3 Dividend Paying Pharma Stocks That Will Profit Off of Rising Obesity Rate
Seeking Alpha
Sunday, July 17, 2011 - 12:06pm
tags:
Novo Nordisk, Eli Lilly, Sanofi, obesity
FDA Cites Risks in Diabetes Drug
Motley Fool
Sunday, July 17, 2011 - 12:04pm
tags:
AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
Don't Get Too Worked Up Over InterMune's Earnings
Motley Fool
Sunday, July 17, 2011 - 12:02pm
tags:
InterMune
Paladin Labs Inc. Announces Purchase of Shares of Afexa Life Sciences Inc.
Benzinga
Saturday, July 16, 2011 - 12:08pm
tags:
Paladin, Afexa
Aptalis Pharma Announces FDA Approval of 25,000 Lipase-Unit Strength of ZENPEP(R)
Pipeline Review
Saturday, July 16, 2011 - 12:07pm
tags:
Aptalis, Zenpep, exocrine pancreatic insufficiency, cystic fibrosis
Valeant aims to become top player in skincare,
Takover Chatter
Saturday, July 16, 2011 - 12:03pm
tags:
Valeant Pharmaceuticals
The Rosen Law Firm Representing Jiangbo Shareholders Files Securities Fraud Class Action Against Jiangbo Pharmaceuticals, Inc.
Yahoo/Marketwire
Saturday, July 16, 2011 - 11:54am
tags:
Jiangbo Pharmaceuticals, lawsuits, legal
Sanofi's Multaq under EU Review
Yahoo/Zacks
Saturday, July 16, 2011 - 11:53am
tags:
Sanofi, Multaq
High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis
Seeking Alpha
Saturday, July 16, 2011 - 11:45am
tags:
AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GSK, Merck, Pfizer, Sanofi
Transcept Announces Plans to Reduce Expenses by Decreasing Staff Following Complete Response Letter from FDA on Intermezzo® New Drug Application
Yahoo/PR NewsWire
Saturday, July 16, 2011 - 11:43am
tags:
Transcept, Intermezzo, insomnia
5 Biotech Takeover / LBO Targets With Bullish Short Trends
Seeking Alpha
Saturday, July 16, 2011 - 11:39am
tags:
Exelixis, InterMune, Dendreon, Savient, Acorda Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.